+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The roles of Dok family adapters in immunoreceptor signaling

The roles of Dok family adapters in immunoreceptor signaling

Immunological Reviews 232(1): 273-285

The mammalian Dok protein family has seven members (Dok-1-Dok-7). The Dok proteins share structural similarities characterized by the NH2-terminal pleckstrin homology and phosphotyrosine-binding domains followed by SH2 target motifs in the COOH-terminal moiety, indicating an adapter function. Indeed, Dok-1 was originally identified as a 62 kDa protein that binds with p120 rasGAP, a potent inhibitor of Ras, upon tyrosine phosphorylation by a variety of protein tyrosine kinases. Among the Dok family, only Dok-1, Dok-2, and Dok-3 are preferentially expressed in hematopoietic/immune cells. Dok-1 and its closest relative Dok-2 act as negative regulators of the Ras-Erk pathway downstream of many immunoreceptor-mediated signaling systems, and it is believed that recruitment of p120 rasGAP by Dok-1 and Dok-2 is critical to their negative regulation. By contrast, Dok-3 does not bind with p120 rasGAP. However, accumulating evidence has demonstrated that Dok-3 is a negative regulator of the activation of JNK and mobilization of Ca2+ in B-cell receptor-mediated signaling, where the interaction of Dok-3 with SHIP-1 and Grb2 appears to be important. Here, we review the physiological roles and underlying mechanisms of Dok family proteins.

(PDF emailed within 0-6 h: $19.90)

Accession: 056490355

Download citation: RISBibTeXText

PMID: 19909370

DOI: 10.1111/j.1600-065X.2009.00844.x

Related references

Organization of immunoreceptor signaling by adapters. Immunological Reviews 232(1): 5-6, 2010

Negative regulation of immunoreceptor signaling by protein adapters: Shc proteins join the club. Febs Letters 584(24): 4915-4922, 2011

Roles for lipid heterogeneity in immunoreceptor signaling. Biochimica et Biophysica Acta 1861(8 Pt B): 830-836, 2016

Novel platelet and vascular roles for immunoreceptor signaling. Arteriosclerosis, Thrombosis, and Vascular Biology 26(12): 2588-2593, 2006

Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Current Opinion in Cell Biology 13(2): 139-145, 2001

Positive and negative regulation of antigen receptor signaling by the Shc family of protein adapters. Immunological Reviews 232(1): 115-134, 2010

GC-GAP, a Rho family GTPase-activating protein that interacts with signaling adapters Gab1 and Gab2. Journal of Biological Chemistry 278(36): 34641-34653, 2003

Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2. Journal of Immunology 172(10): 5838-5842, 2004

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. Blood 99(2): 694-697, 2002

Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology 209(1-2): 179-190, 2004

Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia 61(1): 37-46, 2013

Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. Journal of Biological Chemistry 278(6): 3852-3859, 2002

Adapters in lymphocyte signaling. Journal of Clinical Investigation 109(3): 301-309, 2002

The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells. Immunological Reviews 232(1): 42-58, 2010

LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends in Genetics 14(4): 156-162, 1998